Results 111 to 120 of about 12,065,388 (305)

Spatial and single‐nuclei transcriptomics reveals idiosyncratic and generic patterns in papillary and anaplastic thyroid cancers

open access: yesMolecular Oncology, EarlyView.
Matched spatial transcriptomics and single‐nuclei RNA‐seq were generated for anaplastic and BRAFV600E papillary thyroid cancers revealing generic and tumor‐specific states occurring in cancer cells and in the tumor microenvironment. In this context, cancer dedifferentiation mirrored organoid maturation through ordered thyroid marker gain/loss ...
Adrien Tourneur   +11 more
wiley   +1 more source

Spatial differentiation and driving mechanisms of the Water-Energy-Food-Carbon coupling coordination degree in China

open access: yesShui kexue jinzhan
Dual Carbon Goals and resource constraints make it important to understand the evolutionary characteristics and driving mechanisms of the Water-Energy-Food-Carbon(WEFC) nexus. We propose a spatially adaptive coupling evaluation(SPACE) model that combines
Nan LIU   +5 more
doaj   +1 more source

Inhibition of cyclin‐dependent kinases 12/13 using CT7439 as a treatment for colorectal cancer with CDK12 upregulation

open access: yesMolecular Oncology, EarlyView.
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington   +10 more
wiley   +1 more source

Agricultural New-Quality Productive Forces and Carbon Efficiency: Empirical Evidence from China

open access: yesAgriculture
Enhancing agricultural carbon emission efficiency (ACEE) is a pivotal pathway for advancing environmentally sustainable transformation in agriculture and achieving the ‘dual carbon’ targets.
Liudi Li   +4 more
doaj   +1 more source

Circulating microRNA signatures of cachexia and cancer in Canis familiaris as a comparative oncology model for human disease

open access: yesMolecular Oncology, EarlyView.
Circulating microRNAs as biomarkers of cachexia and sex‐specific cancer in senior dogs. In 25 client‐owned dogs, four circulating miRNAs (miR‐15a, miR‐15b, miR‐16, miR‐140) were downregulated in cachexia, with miR‐16 the strongest individual biomarker (AUC = 0.899).
Soon‐Seok Park   +6 more
wiley   +1 more source

Cadmium in the Soil–Tea–Infusion Continuum of Selenium-Enriched Gardens: Implications for Food Safety

open access: yesFoods
Tea trees (Camellia sinensis) growing on selenium (Se)-rich soils often exhibit the phenomenon of cadmium (Cd) accumulation. However, the transport of Cd in the soil–tea tree–tea infusion continuum in such areas, as well as the impact of Se on Cd in this
Haizhong Wu   +4 more
doaj   +1 more source

CEACAM1 participation in breast cancer progression

open access: yesMolecular Oncology, EarlyView.
In invasive breast cancer (BC), CEACAM1 shifts from an apical to a uniform membranous/cytoplasmic pattern, or is lost, as tumors dedifferentiate, inversely tracking the Ki‐67 proliferative index. In MCF‐7 cells, only CEACAM1‐4L suppresses proliferation, repressing cell cycle and growth factor genes.
Mykola Lyndin   +3 more
wiley   +1 more source

The threshold-crossing effect

open access: yes
THE THRESHOLD-CROSSING EFFECT The threshold-crossing effect (2) OLE_LINK4 (26) OLE_LINK2 (33) OLE_LINK1 (34) OLE_LINK3 ...
Phieler, Ulrike   +2 more
core   +1 more source

The role of core strength in front crawl performance: a qualitative analysis of expert coaches’ perspectives

open access: yesFrontiers in Sports and Active Living
While core strength is theorized to be crucial for swimming performance, empirical evidence remains conflicting, and the perspectives of high-performance coaches—key stakeholders in training prescription-are largely unexplored.
Jinjin Dai, Junjun Xu, Zicheng Dai
doaj   +1 more source

Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer

open access: yesMolecular Oncology, EarlyView.
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy